Ahmed Maher

Kuwait City, KU, Kuwait

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Tumor Necrotic Factor-Alpha (-308A/G, rs1800629) and Interleukin-13 (R130Q, rs20541) Gene Polymorphisms as Predictors of Severe Asthma in Pilot Cohort of Kuwaiti Population: Influence of Age, Nasal Polyps, Fractional Exhaled Nitric Oxide, and Blood Eosinophil Count.

Tumor Necrotic Factor-Alpha (-308A/G, rs1800629) and Interleukin-13 (R130Q, rs20541) Gene Polymorphisms as Predictors of Severe Asthma in Pilot Cohort of Kuwaiti Population: Influence of Age, Nasal Polyps, Fractional Exhaled Nitric Oxide, and Blood Eosinophil Count.

Journal: Journal of asthma and allergy

Published: February 28, 2025

Association between interleukin-6-174G/C gene polymorphism and asthma severity: exploring the role of total serum IgE, blood eosinophils, and FeNO as markers of type 2 inflammation.

Association between interleukin-6-174G/C gene polymorphism and asthma severity: exploring the role of total serum IgE, blood eosinophils, and FeNO as markers of type 2 inflammation.

Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Published: October 06, 2023

Factors influencing poor response to type 2 targeted therapies in severe asthma: a retrospective cohort study.

Factors influencing poor response to type 2 targeted therapies in severe asthma: a retrospective cohort study.

Journal: BMC pulmonary medicine

Published: July 04, 2023

Omalizumab Transitions in Severe Asthma: Factors Influencing Switching Decisions and Timing for Optimal Response.

Omalizumab Transitions in Severe Asthma: Factors Influencing Switching Decisions and Timing for Optimal Response.

Journal: Medical principles and practice : international journal of the Kuwait University, Health Science Centre

Published: May 18, 2023

Severe asthma in Kuwait population: Phenotype-based approach.

Severe asthma in Kuwait population: Phenotype-based approach.

Journal: Respiratory medicine

Published: April 24, 2021

Tolerability of Omalizumab in Asthma as a Major Compliance Factor: 10-Year Follow Up.

Tolerability of Omalizumab in Asthma as a Major Compliance Factor: 10-Year Follow Up.

Journal: Open access Macedonian journal of medical sciences

Published: July 08, 2018

Most common, real life factors affecting effectiveness of omalizumab asthma treatment: a 10-year study.

Most common, real life factors affecting effectiveness of omalizumab asthma treatment: a 10-year study.

Journal: Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina

Published: June 26, 2018

"Real-life" Efficacy and Safety Aspects of 4-Year Omalizumab Treatment for Asthma.

"Real-life" Efficacy and Safety Aspects of 4-Year Omalizumab Treatment for Asthma.

Journal: Medical principles and practice : international journal of the Kuwait University, Health Science Centre

Published: August 30, 2017

Showing 1-8 of 8

Last Updated: 09/26/2026